Where does Fermenta Biotech Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fermenta Biotech Limited ranks #46,704 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Fermenta Biotech Limited hold?

Fermenta Biotech Limited holds 5 US utility patents granted between 2023 and 2025, spanning 8 technology areas.

What is Fermenta Biotech Limited's Innovation Score?

Fermenta Biotech Limited has an Innovation Score of 38.8 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Fermenta Biotech Limited focus on?

Fermenta Biotech Limited's top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 3 patents, ranking #1,234 of 2,691 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Fermenta Biotech Limited's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Fermenta Biotech Limited.

What does claim depth mean for Fermenta Biotech Limited's patents?

Fermenta Biotech Limited's patents average 15.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Fermenta Biotech Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fermenta Biotech Limited

USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fermenta ranks #46,704 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 8 technology areas.

#46,704
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.8/100): 15.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R46704 · Foreign Corporation #46,704 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #46,704/49,997
PHOTO-FINISH FCL Components
CPC-NARROW C07C · 8 areas
INNOV-THIN 38.8/100
CLAIMS-RICH 15.4 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: FCL Components Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fermenta’s 38.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (16%) Velocity 13.3 pts (34%) Breadth 10.0 pts (26%) Claim depth 9.2 pts (24%)

Qualcomm Incorporated · highest

85
Fermenta Biotech · this assignee

39
3D Lighting… · lowest

7

What this shows Fermenta's Innovation Score is 38.8/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Fermenta?

Each dot is one of Fermenta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fermenta’s own 15.4 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Fermenta vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fermenta's grants concentrate

Fermenta Biotech Limited is a focused PatentsView assignee: 8 CPC subclasses with 60% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). By volume, Fermenta sits between FCL Components Limited and Fida, LLC.

Fermenta's three-year grant acceleration

Fermenta Biotech Limited shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

FCL Components

5
FD IP & Licensing

5
Fempro Consumer P…

5
Ferdinand-braun-i…

5
Fetu

5
FFT Produktionssy…

5
Fiberon

5
Fida

5
Fermenta Biotech ◀

5

What this shows Fermenta holds 5 patents at rank #46,692, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fermenta

By rank, the assignees closest to #46,692 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Fermenta's primary technology class.

Fermenta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Fermenta Biotech Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	2	40.0%
2025partial year	3	60.0%

Which technologies does Fermenta Biotech Limited patent most?

C07C - Acyclic OR Carbocyclic Compounds 3

C07J - Steroids 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

Y02W - Climate Change Mitigation Technologies Related TO Wastewater Treatment OR Waste Management 1

C11C - Fatty Acids From Fats, Oils OR WAXES; CANDLES; Fats, Oils OR Fatty Acids BY Chemical Modification OF Fats, Oils, OR Fatty Acids Obtained Therefrom 1

C07D - Heterocyclic Compounds 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C11B - Producing, e.g. BY Pressing RAW Materials OR BY Extraction From Waste Materials, Refining OR Preserving Fats, Fatty Substances, e.g. Lanolin, Fatty Oils OR WAXES; Essential OILS; Perfumes 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Fermenta Biotech Limited's patent record in context - here's where to go next.

Fermenta Biotech Limited's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 60% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #46,704 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Fermenta Biotech Limited against FCL Components Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.